| Literature DB >> 21217853 |
Ludovít Mušák1, Erika Halašová, Tatiana Matáková, Lucia Letková, Ludmila Vodičková, Janka Buchancová, Henrieta Hudečková, Oto Osina, Pavel Souček, Pavel Vodička.
Abstract
Authors compared the incidence of chromosomal aberrations (CAs) of workers occupationally exposed to cytostatics (group EXP1) or anaesthetics (group EXP2) in relationship to polymorphism of GSTM1, GSTP1 and GSTT1 genes. The cytogenetic analysis for chromosomal aberrations frequency and for polymorphisms of genes the PCR and PCR-RFLP method were used. Statistically higher frequency of total CAs was detected in both exposed groups: group EXP1 1.90±1.34%; Mann-Whitney U-test, p=0.001; group EXP2 2.53±1.46%, p=0.0008) as compared to control (1.26±0.93%). In group EXP2 was detected statistically higher frequency of aberrations CSA-type as compared to CTA-type. In xenobiotic metabolizing genes for GST higher frequency of total CAs and constituent types chromatid-type aberrations (CTAs) and chromosome-type aberrations (CSAs) of genes GSTM1 and GSTT1 with null genotype was detected. Statistically significant difference was detected only in CSA-type of aberrations in GSTT1 gene. In gene GSTP1 was not detected any difference in frequency of aberrations in presence of the variant allele. Presented results point out importance of individual susceptibility in evaluation of genotoxic agents of anaesthetics or cytostatics.Entities:
Keywords: anaesthetics; chromosomal aberrations; cytostatics; occupational exposure; polymorphisms of GST genes
Year: 2009 PMID: 21217853 PMCID: PMC2984104 DOI: 10.2478/v10102-009-0016-0
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Characteristics of exposed groups and control.
| EXP1 | EXP2 | Control | |
|---|---|---|---|
| Number | 72 | 76 | 76 |
| Age (years±S.D.) | 41.19±8.95 | 36.89±8.75 | 35.99±7.73 |
| Exposure (years±S.D.) | 11.31±8.98 | 11.75±9.35 | |
| Sex (N) M/F | 7 / 65 | 15 / 61 | 16 / 60 |
| Smoking (N) S/NS | 19 / 53 | 23 / 53 | 15 / 61 |
| Job (N) physician/nurse | 14 / 58 | 41 / 35 | 20 / 56 |
Figure 1Polymorphisms of GSTM1 gene in exposed group to cytostatics.
Figure 2Polymorphisms of GSTM1 gene in exposed group to anaesthetics.
Figure 3Polymorphisms of GSTM1 gene in control group.
Figure 4Polymorphisms of GSTP1 gene in exposed group to cytostatics.
Figure 5Polymorphisms of GSTP1 gene in exposed group to anaesthetics.
Figure 6Polymorphisms of GSTP1 gene in control group.
Figure 7Polymorphisms of GSTT1 gene in exposed group to cytostatics.
Figure 8Polymorphisms of GSTT1 gene in exposed group to anaesthetics.
Figure 9Polymorphisms of GSTT1 gene in control group.
Chromosomal aberrations expressed percentage in exposed groups and control.
| Number of mitosis (N) | Number of Ab.c. (N) | Percentage of CAs (%)±S.D. | |
|---|---|---|---|
| EXP1 - cytostatics | 7200 | 137 | 1.90±1.34 |
| EXP2 - anaesthetics | 7600 | 192 | 2.53±1.46 |
| Control | 7600 | 96 | 1.26±0.93 |
*** p=0.001 (EXP1)
*** p=0.0008 (EXP2)-total CAs exposed vs. control